AstraZeneca seeks set aside of post-M&A award in Germany
Munich, Bavaria (Credit: Shutterstock/Travel Faery)
AstraZeneca has applied to a German court to set aside a US$46.4 million German Arbitration Institute (DIS) award over milestone payments for its purchase of a cancer diagnostics start-up.
To read more
Subscribe to Global Arbitration Review
Register for limited access
Register for free to receive GAR’s daily briefing and access to GAR 100.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Subscribe now